BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3789691)

  • 1. Effect of saturable serum protein binding on the pharmacokinetics of unbound cefonicid in humans.
    Dudley MN; Shyu WC; Nightingale CH; Quintiliani R
    Antimicrob Agents Chemother; 1986 Oct; 30(4):565-9. PubMed ID: 3789691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple-dose pharmacokinetics of cefonicid in patients with impaired renal function.
    Phelps RT; Conte JE
    Antimicrob Agents Chemother; 1986 May; 29(5):913-7. PubMed ID: 3729349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the unbound concentration of cefonicid on its renal elimination in isolated perfused rat kidneys.
    Rodriguez CA; Smith DE
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2395-400. PubMed ID: 1804013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of cefonicid in uraemic patients.
    Fillastre JP; Fourtillan JB; Leroy A; Ramis N; Lefevre MA; Reumont G; Humbert G
    J Antimicrob Chemother; 1986 Aug; 18(2):203-11. PubMed ID: 3759731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of cefonicid, a new broad-spectrum cephalosporin.
    Barriere SL; Hatheway GJ; Gambertoglio JG; Lin ET; Conte JE
    Antimicrob Agents Chemother; 1982 Jun; 21(6):935-8. PubMed ID: 7114840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritoneal transport of cefonicid.
    Morse GD; Lane T; Nairn DK; Deterding J; Curry J; Gal P
    Antimicrob Agents Chemother; 1987 Feb; 31(2):292-4. PubMed ID: 3566253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics and renal handling of cefonicid.
    Pitkin D; Dubb J; Actor P; Alexander F; Ehrlich S; Familiar R; Stote R
    Clin Pharmacol Ther; 1981 Nov; 30(5):587-93. PubMed ID: 7297018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of cefonicid in children.
    Furlanut M; D'Elia R; Riva E; Pasinelli F
    Eur J Clin Pharmacol; 1989; 36(1):79-82. PubMed ID: 2917594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition of cefonicid in orthopedic surgery patients.
    Ackerman BH; Trang JM; Nelson CL; Pearce CE; Manning JT; Harrison BH
    Drug Intell Clin Pharm; 1988 Nov; 22(11):864-8. PubMed ID: 3234250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefonicid kinetics in subjects with normal and impaired renal function.
    Blair AD; Maxwell BM; Forland SC; Jacob L; Cutler RE
    Clin Pharmacol Ther; 1984 Jun; 35(6):798-803. PubMed ID: 6734031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-over study of the pharmacokinetics of cefonicid administered intravenously or intramuscularly to healthy adult humans.
    Fourtillan JB; Leroy A; Lefebvre MA; Humbert G; Fillastre JP; Reumont G; Ramis N
    Eur J Drug Metab Pharmacokinet; 1985; 10(3):225-30. PubMed ID: 3936717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of cefonicid in patients with skin and skin structure infections.
    Heim-Duthoy KL; Peltier GL; Guay DR; Matzke GR
    Antimicrob Agents Chemother; 1988 Apr; 32(4):485-7. PubMed ID: 3377460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of cefonicid in serum and its penetration into lung tissue, bronchial mucosa and pleura.
    Furlan G; Besa G; Broccali G; Gusmitta A
    Int J Clin Pharmacol Res; 1989; 9(1):49-53. PubMed ID: 2707925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic disposition of cefonicid in patients with renal failure and receiving hemodialysis.
    Barriere SL; Gambertoglio JG; Alexander DP; Stagg RJ; Conte JE
    Rev Infect Dis; 1984; 6 Suppl 4():S809-15. PubMed ID: 6522922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of age and renal function on cefonicid pharmacokinetics.
    Trang JM; Monson TP; Ackerman BH; Underwood FL; Manning JT; Kearns GL
    Antimicrob Agents Chemother; 1989 Feb; 33(2):142-6. PubMed ID: 2719458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of protein binding on drug penetration into blister fluid.
    Shyu WC; Quintiliani R; Nightingale CH; Dudley MN
    Antimicrob Agents Chemother; 1988 Jan; 32(1):128-30. PubMed ID: 3162360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefonicid concentrations in human aqueous humor.
    Axelrod JL; Kochman RS
    Arch Ophthalmol; 1984 Mar; 102(3):433-4. PubMed ID: 6608343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro experience with cefonicid.
    Actor P
    Rev Infect Dis; 1984; 6 Suppl 4():S783-90. PubMed ID: 6522920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of pharmacokinetics.
    Cutler RE
    Rev Infect Dis; 1984; 6 Suppl 4():S803-8. PubMed ID: 6522921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penetration of cefonicid in skin suction blister fluid in healthy volunteers.
    Cruciani M; Concia E; Passarella E; Soncini R
    Int J Clin Pharmacol Res; 1987; 7(3):225-7. PubMed ID: 3596863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.